Vancive Medical Technologies has announced it will offer six advanced wound care materials for private...
The BeneHold™ range of hydrocolloid wound dressings uses Vancive’s unique and propriety next-generation adhesive formulations.
Unlike traditional hydrocolloids, the materials remain highly integrated, cleanly removing from the wound bed and periwound skin. The adhesive is odourless, unlike conventional hydrocolloids.
A patented Vancive hydrocolloid adhesive formulation incorporates cyclodextrins, which entrap and absorb offending odorant molecules.
BeneHold Bordered Hydrocolloid Dressing with odour control was subjected to a ten patient clinical evaluation. Clinicians documented their impressions of the dressing throughout the evaluation period, which lasted up to four weeks.
Efficient moisture management
BeneHold’s advanced hydrocolloid technology offers maximum absorption, while remaining thin. When absorbing exudate, the adhesive layer remains intact and does not break down in the wound bed.
Designed for patient comfort
Conformable, low-friction polyurethane film and low profile edges enable fewer dressing changes and extended wear time.
The bordered dressing features a patented hydrocolloid formulation that contains cyclodextrins, which entrap and absorb offending odorant molecules.
Facilitates autolytic debridement
By providing a moist environment to support the body’s natural process for reducing and softening eschar, BeneHold helps wounds to heal.
Vancive has announced it will be an exhibiting at MD&M West this year. The conference...
This study's aim was to quantify and understand the adhesive performance of acrylic pressure-sensitive skin...
Vancive Medical Technologies has announced it will unveil ten new medical adhesive tapes at Medica...